Biotechnology firm Genzyme Corp. said Thursday that it was buying Ilex Oncology Inc. for $1 billion in stock to bolster its business of providing drugs to treat cancer. Genzyme, based in Cambridge ...

NEW YORK (MarketWatch) -- Genzyme Corp. Tuesday said it's increasing its proposal to acquire AnorMED Inc. to $580 million, or $13.50 per share. The bid represents an effort by Genzyme to trump the ...

French drugmaker Sanofi-Aventis SA clinched its long-sought deal for Genzyme Corp with a sweetened $20.1 billion cash offer, plus payments tied to the success of the U.S. biotech group's drugs.

Genzyme Corporation's Hylastan Misses Goal in Arthritis Trial CAMBRIDGE, Mass., July 5 -- Genzyme Corp. today announced top-line results from a pivotal study investigating the safety and efficacy ...

Genzyme Corp. will be paying a settlement to resolve allegations that it inappropriately marketed a surgical device. Cambridge-based biotech Genzyme Corp. will be paying a $32.5 million settlement ...

Genzyme Corp.'s fourth-quarter earnings dropped 73% because of manufacturing problems that the maker of rare-disease treatments expects to continue to hurt earnings this year. The Cambridge, Mass ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Genzyme Corporation (Nasdaq: GENZ) announced results today from its CLASSIC I phase 3 trial comparing Clolar® (clofarabine) in combination with the chemotherapy ...

NEW YORK (MarketWatch) -- Genzyme Corp. said Wednesday that second-quarter earnings were $192 million, or 70 cents a share, compared to $70 million, or 25 cents a share, in the year-ago period. On ...

CAMBRIDGE, Mass. and SOUTH PLAINFIELD, N.J., July 17 /PRNewswire- FirstCall/ -- Genzyme Corporation (Nasdaq: GENZ) and PTC Therapeutics, Inc. (PTC) today announced an exclusive global collaboration ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Genzyme Corporation (Nasdaq: GENZ) announced today that the FDA has granted U.S. marketing approval for Lumizyme™ (alglucosidase alfa), produced at the 4000 liter ...

Genzyme Corp. has recalled nine lots of thymoglobulin, a medication designed to treat acute kidney transplant rejection, according to the U.S. Food and Drug Administration. The recall was initiated… ...